poisar

Stocks · News reference

Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal

BenzingaAug 21, 2026, 1:33 PMVandana Singh

Werewolf Therapeutics and Ambros Therapeutics merge in an all-stock deal with $150M in financing to advance Phase 3 CRPS-1 candidate.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 21, 2026, 1:33 PM
Checked
Aug 21, 2026, 1:33 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading